1. The Pulmonologist’s Role in Improving Personalized Diagnosis and Treatment of NSCLC

2. Lung Cancer Screening

3. NLST Study Design

4. NLST Lung Cancer Mortality

5. Lung Cancer Screening 2013 Recommendations From the USPSTF

6. Lung Cancer Screening Issues Related to Effective Implementation

7. Reclassifying Lung Adenocarcinoma Recommendations from IASLC/ATS/ERS

8. Resection Specimens IASLC/ATS/ERS Recommendations for Classification of Adenocarcinoma

9. Small Biopsies and Cytologic Specimens Highlights From IASLC/ATS/ERS Recommendations

10. Biopsy Procedures and Issues in Advanced NSCLC

11. Sampling in Suspected Advanced NSCLC

12. Transthoracic Core Needle Biopsy in BATTLE Lung Trial

13. Cytologic Specimens for Histologic Subtyping and Genotyping EBUS-TBNA

14. Biopsy Issues Best Practices in the Setting of Suspected Advanced NSCLC

15. Limitations of NSCLC-NOS

16. Effect of NSCLC-NOS on Treatment Selection in Advanced NSCLC

17. Effect of NSCLC-NOS on Treatment Selection in Advanced NSCLC (cont)

18. Molecular Testing Guidelines CAP/ASIP/AMP/IASLC

19. Molecular Testing Guidelines Who, When, and What of EGFR and ALK Testing

20. ROSE

21. ROSE Suggested Algorithm for Processing EBUS-TBNA Specimens

22. Abbreviations

23. References

24. References (cont)

25. References (cont)

26. References (cont)